Products & ReviewClinical Diagnostics

SARS-CoV-2 & RSV

LumiraDxAvailable: Worldwide

Is it RSV? Is it COVID-19? Actionable results in minutes. Verify potential infection and help guide infection control measures quickly with a rapid microfluidic assay that provides actionable results in 12 minutes, for patients suspected of RSV and/or COVID-19.

Request Pricing
LumiraDx

Receive your quote directly from the manufacturer.

Ease of Use
After Sales Service
Value for Money
Write your own review

Test benefits

  • Microfluidic immunofluorescence assay
  • Optimize patient and clinical flow - 1 sample, 2 results, 12 minutes
  • Helps guide infection control measures quickly
  • Sample Type: nasal swab
  • Prepared sample can also be used with LumiraDx SARS-Cov-2 & Flu A/B Test
  • Easy to implement at point of care
  • Time to result in as quick as 12 minutes
  • No refrigeration storage required: room temperature storage (2-30°C)
  • Minimal handling steps
  • Small and portable Instrument

Product Overview

Links